Facilitators of adherence to the study pill in the FEM-PrEP clinical trial.
INTRODUCTION:FEM-PrEP did not demonstrate a reduction in HIV acquisition because of low study pill adherence. Yet, plasma and intracellular drug concentrations indicated that some participants had evidence of recent pill use. We conducted a follow-up study to identify, among other topics, participan...
Main Authors: | Amy Corneli, Brian Perry, Kawango Agot, Khatija Ahmed, Fulufhelo Malamatsho, Lut Van Damme |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4395082?pdf=render |
Similar Items
-
The sexual risk context among the FEM-PrEP study population in Bondo, Kenya and Pretoria, South Africa.
by: Jennifer Headley, et al.
Published: (2014-01-01) -
Preparing for the Rollout of Pre-Exposure Prophylaxis (PrEP): A Vignette Survey to Identify Intended Sexual Behaviors among Women in Kenya and South Africa if Using PrEP.
by: Amy Corneli, et al.
Published: (2015-01-01) -
My PrEP Locator: PrEP directory in Malaysia
by: M.L. Chong, et al.
Published: (2020-12-01) -
Lessons learnt from implementing an empirically informed recruitment approach for FEM-PrEP, a large HIV prevention clinical trial
by: Parker C, et al.
Published: (2014-12-01) -
“PrEP”ing for a PrEP demonstration project: understanding PrEP knowledge and attitudes among cisgender women
by: Elizabeth C. Pasipanodya, et al.
Published: (2021-05-01)